Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7539944 | 1.00 | TSHR (0.36) | TSHRTDP1CYP2D6 | |
| SCHEMBL11821806 | 0.83 | ALDH1A1 (0.37) | — | |
| SCHEMBL16187773 | 0.83 | — | — | |
| SCHEMBL11854359 | 0.83 | — | — | |
| SCHEMBL9883162 | 0.83 | CYP2D6 (0.53) | CYP2D6 | |
| SCHEMBL11430858 | 0.83 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL11424207 | 0.83 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL11242160 | 0.83 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL5599274 | 0.83 | — | — | |
| SCHEMBL159070 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014192020-A2 | A PROCESS FOR PREPARING ALKENE FROM ALKANE | RELIANCE INDUSTRIES LIMITED (IN) | 2014-12-04 | — | — | WO | claimed |
| WO-2014128717-A2 | A PROCESS FOR DEHYDROGENATING ALKANE TO ALKADIENE | RELIANCE INDUSTRIES LIMITED (IN) | 2014-08-28 | — | — | WO | claimed |
| WO-2014192020-A2 | A PROCESS FOR PREPARING ALKENE FROM ALKANE | RELIANCE INDUSTRIES LIMITED (IN) | 2014-12-04 | — | — | WO | disclosed |
| WO-2014128717-A2 | A PROCESS FOR DEHYDROGENATING ALKANE TO ALKADIENE | RELIANCE INDUSTRIES LIMITED (IN) | 2014-08-28 | — | — | WO | disclosed |